Geninus (389030.KQ) Stock Price

Geninus Price

CLOSED
2,105.00
​
Market closed

Over the last 6 years Geninus grew revenue by 40.3% annually, reaching 10.48 B KRW. For Geninus, the net margin of -165.7% is down versus -110.9% a few years ago.

Geninus stock price

Access this data via the Eulerpool API

Geninus business model & stock analysis

GENINUS, Inc. is engaged in the research and development of NGS (Next Generation Sequencing)-based genome analysis technology, development and manufacturing of genome analysis solutions. The company is headquartered in Seoul, Seoul and currently employs 94 full-time employees. The company went IPO on 2021-11-08. The firm is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. The company is also engaged personal genetic testing, software development, rental business and others.

Frequently asked questions about Geninus

Converted at the current exchange rate, the Geninus share trades at 1.40 EUR (2,105.00 KRW).

The revenue cannot currently be calculated for Geninus.

The profit cannot currently be calculated for Geninus.

The P/E ratio cannot be calculated for Geninus at the moment.

The P/S cannot be calculated for Geninus currently.

The Eulerpool Quality Score for Geninus is 2/10.

The ISIN of Geninus is KR7389030008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Geninus is 389030.KQ. The ticker symbol is used to trade Geninus shares on the stock exchange.

Fair ValueTerminal
1,999.75 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
111.53 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 8, 2021
ISIN
KR7389030008
Cusip
Y2692J100
Market capitalization
70.16 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
7.71
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-190.88 %
Last updated Oct 8, 2026, 6:03 AM

Geninus Peer Group

Geninus FIGI

389030:KS · BBG012PLRTV3389030:KQ · BBG012PLRTX1

All fundamentals and in-depth analysis of Geninus

Our stock analysis for Geninus stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Geninus. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.